<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210226050508N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-05-31</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Assessment of therapeutic effects of Iranian Nava musical dastgah on Sciatica and comparing it with the conventional medical treatment: a randomised control trial</public_title>
      <acronym></acronym>
      <scientific_title>Assessment of therapeutic effects of Iranian Nava musical dastgah on Sciatica and comparing it with the conventional medical treatment: a randomised control trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>112</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/55275</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: This is the first clinical study dedicated specifically to the therapeutic effects of the Iranian Nava music Dastgah, Randomization description: Randomisation method: stratified randomization; unit of randomization: odds and even; randomization layers: moderate to severe pain severity; randomization tool:  first, the recruits are divided into moderate and severe groups according to the pain severity, then in each category, randomization is performed by block method. Quadruple blocks are selected using a random number table and a random list is prepared.
Concealment: a sealed envelope is used. The patient number is written on the envelope and inside the A&amp;B group envelope, Blinding description: In this study, those who cared for patients and provided them with lottery bags and music, and those who collected data and analyzers did not know the study groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Low back pain (Sciatica).</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: along side receiving standard treatment and care, every night, the recruits in the intervention group listens to a musical piece in "Mirza abdollah" Radif and Iranian "Nava" musical dastgah for 5 minutes. This piece is performed by Master Aliasghar Bayani using a "Setar" instrument. Intervention 2: Control group: The recruits in control group receive standard treatment and care. the standard care includes home rest, warm compression of the pain field, and 500 mg acetaminophen tablet intake (1-4 tabs per day in relation to the patient's pain).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mona Haghighi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Traditional Medicine, No 847, Behesht St. South Side of Shahr Park, Vahdat-e-Islami St., Hasan Abad Sq., Tehran, Iran.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1114733311</zip>
        <telephone>+9855580388</telephone>
        <email>dr.mona.haghighi@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mona Haghighi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 847, Behesht St. South Side of Shahr Park, Vahdat-e-Islami St., Hasan Abad Sq., Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1114733311</zip>
        <telephone>+98 21 5558 0388</telephone>
        <email>dr.mona.haghighi@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of sciatica or radicular low back pain (low back pain spreading to the lower limbs below the knee) based on clinical examination or MRI
Less than two weeks after the onset of pain (continuous or intermittent)
Age: 35 to 65 years old
Moderate to severe pain intensity at the start of treatment (VAS greater than or equal to 4)
No indication for lumbar spine surgery
No hearing problems
No history of seizures and noise-aggravated brain lesions(Reflex Epilepsy )
Fluency in Persian</inclusion_criteria>
      <agemin>35 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Age less than 35 and more than 65
History of previous lumbar spine surgery
Symptoms of cauda equina‏ syndrome (numbness and weakness of both legs, anal pain, perineal anesthesia, sphincter paralysis)
Existence of low back pain with specific causes such as fractures, cancer, systemic inflammation and rheumatic diseases, infection and severe degenerative changes
Symptoms during treatment that the doctor thinks need further investigation and intervention, such as diseases of other organs
Pregnancy
Causes hearing problems or noise-aggravated brain damage
A history of corticosteroid or opioid use in the last six weeks for any reason
Patient dissatisfaction</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.30</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Sciatica, unspecified side</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: along side receiving standard treatment and care, every night, the recruits in the intervention group listens to a musical piece in "Mirza abdollah" Radif and Iranian "Nava" musical dastgah for 5 minutes. This piece is performed by Master Aliasghar Bayani using a "Setar" instrument.</i_keyword>
      <i_keyword>Control group: The recruits in control group receive standard treatment and care. the standard care includes home rest, warm compression of the pain field, and 500 mg acetaminophen tablet intake (1-4 tabs per day in relation to the patient's pain).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>VAS (Visual Analogue Scale). Timepoint: At the beginning of the study, the tenth day and the thirtieth day. Method of measurement: Visual Analogue Scale questionnaire.</prim_outcome>
      <prim_outcome>Roland- Morris disability questionnaire score. Timepoint: At the beginning of the study, the tenth day and the thirtieth day. Method of measurement: Roland- Morris disability questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Speilberger State – Trait Anxiety Inventory score. Timepoint: At the beginning of the study, the tenth day and the thirtieth day. Method of measurement: Speilberger State – Trait Anxiety Inventory.</sec_outcome>
      <sec_outcome>Daily consumption of analgesic medication. Timepoint: At the beginning of the study, the tenth day and the thirtieth day. Method of measurement: Questionnaire.</sec_outcome>
      <sec_outcome>Salmannezhad Mizaj Identification Questionnaire score. Timepoint: At the beginning of the study. Method of measurement: Salmannezhad Mizaj Identification Questionnaire in Persian Medicine.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-02-13</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Iran University of Medical Sciences, Hemmat Highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
